Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Collaborative Neuroscience Research, LLC, Los Alamitos, California Research Centers of America ( Hollywood ), Hollywood, Florida Innovative Clinical Research, Inc., Miami Lakes, Florida Atlanta Center for Medical Research, Atlanta, Georgia CenExel iResearch, LLC, Decatur, Georgia